SEC Form D filing

Gaius Therapeutics, Inc,

Biotech · Seed · Regulation D 506(b) · CA · Filed May 14, 2026

Offering amount
$250.0K
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
May 14, 2026
Signature date
—
CIK
0002132841

Summary

$250k Gaius Therapeutics early-stage biotech in seed range.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.